Differential clearance of rat and human bone marrow-derived mesenchymal stem cells from the brain after intra-arterial infusion in rats

Cell Transplantation

Volumn 24, Issue 5, 2015, Pages 819-828

  Khabbal, Joonas ^a   Kerkelä, Erja ^b   Mitkari, Bhimashankar ^a   Raki, Mari ^c   Nystedt, Johanna ^b   Mikkonen, Ville ^a   Bergström, Kim ^c,d   Laitinen, Saara ^b   Korhonen, Matti ^b   Jolkkonen, Jukka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Biodistribution; Bone marrow derived mesenchymal cells (BM MSCs); Cerebral ischemia; Intra arterial (IA) delivery; Single photon emission computed tomography (SPECT) imaging; Xenografting

Indexed keywords

TECHNETIUM 99M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN CELL; CONTROLLED STUDY; DRUG CLEARANCE; ENGRAFTMENT; EXTERNAL CAROTID ARTERY; HEMISPHERE; HUMAN; HUMAN CELL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RADIATION MEASUREMENT; RADIOACTIVITY; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; XENOTRANSPLANTATION; ANIMAL; BONE MARROW CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; RADIOGRAPHY; STROKE; WISTAR RAT; XENOGRAFT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; BONE MARROW CELLS; HETEROGRAFTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, WISTAR; STROKE;

EID: 84928955719     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368914X679336     Document Type: Article

References (36)

1. Andrews, E. M.; Tsai, S. Y.; Johnson, S. C.; Farrer, J. R.; Wagner, J. P.; Kopen, G. C.; Kartje, G. L. Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp. Neurol. 211:588–592; 2008.
2. Arbab, A. S.; Thiffault, C.; Navia, B.; Victor, S. J.; Hong, K.; Zhang, L.; Jiang, Q.; Varma, N. R. S.; Iskander, A. S. M.; Chopp, M. Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging. BMC Med. Imaging 12:33; 2012.
3. Azizi, S. A.; Stokes, D.; Augelli, B. J.; DiGirolamo, C.; Prockop, D. J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc. Natl. Acad. Sci. USA. 95:3908–3913; 1998.
4. Banerjee, S.; Williamson, D. A.; Habib, N.; Chataway, J. The potential benefit of stem cell therapy after stroke: An update. Vasc. Health Risk Manag. 8:569–580; 2012.
5. Barker, R. A.; Widner, H. Immune problems in central nervous system cell therapy. NeuroRx 1:472–481; 2004.
6. Bonita, R.; Solomon, N.; Broad, J. B. Prevalence of stroke and stroke-related disability. Estimates from the Auckland stroke studies. Stroke 28:898–902; 1997.
7. Brenneman, M.; Sharma, S.; Harting, M.; Strong, R.; Cox, Jr., C. S.; Aronowski, J.; Grotta, J. C.; Savitz, S. I. Autolo-gous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J. Cereb. Blood Flow Metab. 30:140–149; 2010.
8. Chen, J.; Li, Y.; Wang, L.; Lu, M.; Zhang, X.; Chopp, M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 189:49–57; 2001.
9. Coyne, T. M.; Marcus, A. J.; Woodbury, D.; Black, I. B. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells. 24:2483–2492; 2006.
10. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D. J.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317; 2006.
11. Fischer, U. M.; Harting, M. T.; Jimenez, F.; Monzon-Posadas, W. O.; Xue, H.; Savitz, S. I.; Laine, G. A.; Cox, Jr., C. S. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev. 18: 683–692; 2009.
12. Haefliger, P.; Agorastos, N.; Renard, A.; Giambonini-Brugnoli, G.; Marty, C.; Alberto, R. Cell uptake and radio-toxicity studies of an nuclear localization signal peptide-intercalator conjugate labeled with [99mTc(CO)3]+. Bioconjug. Chem. 16:582–587; 2005.
13. Hess, D. C.; Hill, W. D. Cell therapy for ischaemic stroke. Cell Prolif. 44 (Suppl 1):1–8; 2011.
14. Irons, H.; Lind, J. G.; Wakade, C. G.; Yu, G.; Hadman, M.; Carroll, J.; Hess, D. C.; Borlongan, C. V. Intracerebral xenotransplantation of GFP mouse bone marrow stromal cells in intact and stroke rat brain: Graft survival and immu-nologic response. Cell Transplant. 13:283–294; 2004.
15. Janowski, M.; Lyczek, A.; Engels, C.; Xu, J.; Lukomska, B.; Bulte, J. W.; Walczak, P. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J. Cereb. Blood Flow Metab. 33: 921–927; 2013.
16. Kerkelä, E.; Hakkarainen, T.; Mäkelä, T.; Raki, M.; Kambur, O.; Kilpinen, L.; Nikkilä, J.; Lehtonen, S.; Ritamo, I.; Pernu, R.; Pietilä, M.; Takalo, R.; Juvonen, T.; Bergström, K.; Kalso, E.; Valmu, L.; Laitinen, S.; Lehenkari, P.; Nystedt, J. Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue. Stem Cells Transl. Med. 2:510–520; 2013.
17. Lappalainen, R.; Narkilahti, S.; Huhtala, T.; Liimatainen, T.; Suuronen, T.; Närvänen, A.; Suuronen, R.; Hovatta, O.; Jolkkonen, J. SPECT imaging shows accumulation of stem cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci. Lett. 440: 246–250; 2008.
18. Li, J.; Ezzelarab, M. B.; Cooper, D. K. Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation 19:273–285; 2012.
19. Li, Y.; Chen, J.; Chen, X. G.; Wang, L.; Gautam, S. C.; Xu, Y. X.; Katakowski, M.; Zhang, L. J.; Lu, M.; Janakiraman, N.; Chopp, M. Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery. Neurology 59:514–523; 2002.
20. Longa, E. Z.; Weinstein, P. R.; Carlson, S.; Cummins, R. Reversible middle cerebral artery occlusion without crani-ectomy in rats. Stroke 20:84–91; 1989.
21. Mäkinen, S.; Kekarainen, T.; Nystedt, J.; Liimatainen, T.; Huhtala, T.; Närvanen, A.; Laine, J.; Jolkkonen, J. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res. 1123:207–215; 2006.
22. Mendez-Otero, R.; de Freitas, G. R.; Andre, C.; de Mendonca, M. L.; Friedrich, M.; Oliveira Filho, J. Potential roles of bone marrow stem cells in stroke therapy. Regen. Med. 2:417–423; 2007.
23. Mitkari, B.; Kerkelä, E.; Nystedt, J.; Korhonen, M.; Huhtala, T.; Jolkkonen, J. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells result in transient localization in the brain after cerebral ischemia in rats. Exp. Neurol. 239:158–162; 2013.
24. Molina, C. A. Reperfusion therapies for acute ischemic stroke: Current pharmacological and mechanical approaches. Stroke 42:S16–19; 2011.
25. Mäkinen, S.; Kekarainen, T.; Nystedt, J.; Liimatainen, T.; Huhtala, T.; Närvanen, A.; Laine, J.; Jolkkonen, J. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Res. 1123:207–215; 2006.
26. Puurunen, K.; Jolkkonen, J.; Sirviö, J.; Haapalinna, A.; Sivenius, J. An a2-antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats. Neuropharmacology 40:597–606; 2001.
27. Raki, M.; Bergström, K.; Jolkkonen, J. In vivo biodistribution studies and cell tracking in stroke using SPECT imaging. In: Jolkkonen, J.; Walczak, P., eds. Cell-Based Therapies in Stroke. Vienna, Austrai: Springer; 2013:137–149.
28. Rosado-de-Castro, P. H.; Pimentel-Coelho, P. M.; Barbosa da Fonseca, L. M.; de Freitas, G. R.; Mendez-Otero, R. Stem Cells Dev. 22:2095–2111; 2013.
29. Rosenblum, S.; Wang, N.; Smith, T. N.; Pendharkar, A. V.; Chua, J. Y.; Birk, H.; Guzman, R. Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke 43: 1624–1631; 2012.
30. Rossignol, J.; Boyer, C.; Thinard, R.; Remy, S.; Dugast, A. S.; Dubayle, D.; Dey, N. D.; Boeffard, F.; Delecrin, J.; Heymann, D.; Vanhove, B.; Anegon, I.; Naveilhan, P.; Dunbar, G. L.; Lescaudron, L. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xeno-transplantation. J. Cell Mol. Med. 13:2547–2558; 2009.
31. Schallmoser, K.; Bartmann, C.; Rohde, E.; Reinisch, A.; Kashofer, K.; Stadelmeyer, E.; Drexler, C.; Lanzer, G.; Linkesch, W.; Strunk, D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47:1436–1446; 2007.
32. Uccelli, A.; Moretta, L.; Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8:726–736; 2008.
33. von Bahr, L.; Batsis, I.; Moll, G.; Hägg, M.; Szakos, A.; Sundberg, B.; Uzunel, M.; Ringden, O.; Le Blanc, K. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 30:1575–1578; 2012.
34. Willing, A. E.; Shahaduzzaman, M. Delivery routes for cell therapy in stroke. In: Jolkkonen, J.; Walczak, P., eds. Cell-Based Therapies in Stroke. Vienna, Austrai: Springer; 2013:15–28.
35. Yang, M.; Wei, X.; Li, J.; Heine, L. A.; Rosenwasser, R.; Iacovitti, L. Changes in host blood factors and brain glia accompanying the functional recovery after systemic administration of bone marrow stem cells in ischemic stroke rats. Cell Transplant. 19:1073–1084; 2010.
36. Zhao, L. R.; Duan, W. M.; Reyes, M.; Keene, C. D.; Verfaillie, C. M.; Low, W. C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174:11–20; 2002.